553 results on '"Lilleyman, J."'
Search Results
2. Non-Compliance With Oral Chemotherapy In Childhood Leukaemia: An Overlooked And Costly Cause Of Late Relapse
3. Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia
4. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials
5. Finagleʼs Elixir: AW03
6. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial
7. TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis: 119
8. CHILDHOOD LEUKAEMIA: A RELATIONSHIP BETWEEN INTRACELLULAR 6-MERCAPTOPURINE METABOLITES AND NEUTROPENIA
9. Human thiopurine methyltransferase activity varies with red blood cell age
10. 6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations
11. Reflecting on Redfern: What can we learn from the Alder Hey story?: Commentary
12. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)
13. THE FUTURE OF HEALTH CARE PROFESSIONALS: THE COLLEGE OF PATHOLOGISTS' VIEW.
14. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations
15. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity
16. Neoplastic diseases of childhood
17. Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X
18. Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin
19. Profile of non-compliance in lymphoblastic leukaemia
20. 6-Mercaptopurine Metabolism in Childhood Leukaemia: PI-25
21. Mean cell haemoglobin concentration in subjects with haemoglobin C, D, E and S traits
22. Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites
23. Lymphoblastic leukaemia and non-Hodgkin's lymphoma
24. Difficulty in applying discriminant function to patients with HbE trait
25. Lymphocyte subset counts in skin puncture and venous blood compared
26. Changes in cytomorphology of childhood lymphoblastic leukaemia at the time of disease relapse
27. Hepatitis C virus infection in multi-transfused children with haematological malignancy
28. Frequency of coincident iron deficiency and beta-thalassaemia trait in British Asian children
29. How to write a scientific paper-a rough guide to getting published
30. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials*
31. Treatment of childhood immune thrombocytopenic purpura
32. Wolfram syndrome: mitochondrial disorder
33. Junior Hospital Staff Contract
34. Cellular Hyperviscosity As A Cause Of Neurological Symptoms In Leukaemia
35. Shwachman's Syndrome And Acute Lymphoblastic Leukaemia
36. A Hundred And Still Going Strong
37. Long Term Management After Splenectomy
38. Immunological Lymphocyte Markers in Lymphoid Neoplasia
39. Medical Research Council Childhood Leukaemia Trial VIII Compared with Trials II–VII: Lessons for Future Management
40. A third intensive block of treatment at 35 weeks improves outcome in childhood ALL: Preliminary results from the UKALLXI and ALL97 randomised trials
41. CHILDREN UNDER 2 YEARS TREATED ACCORDING TO THE MEDICAL-RESEARCH-COUNCIL UKALL-VIII STUDY AND TRIAL 1980-1984 (ON BEHALF OF THE MEDICAL-RESEARCH-COUNCIL WORKING PARTY ON LEUKEMIA IN CHILDHOOD)
42. Late relapsing childhood acute lymphoblastic leukaemia
43. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
44. The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
45. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials
46. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia
47. Late relapsing childhood lymphoblastic leukaemia
48. Medical Research Council Childhood Leukaemia Trial VIII Compared with Trials II–VII: Lessons for Future Management
49. Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial
50. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.